Total submissions: 2
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Labcorp Genetics |
RCV000555341 | SCV000642642 | uncertain significance | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2017-02-05 | criteria provided, single submitter | clinical testing | |
| Ambry Genetics | RCV000618758 | SCV000737158 | uncertain significance | Cardiovascular phenotype | 2016-09-07 | criteria provided, single submitter | clinical testing | The p.N3533S variant (also known as c.10598A>G), located in coding exon 44 of the TTN gene, results from an A to G substitution at nucleotide position 10598. The asparagine at codon 3533 is replaced by serine, an amino acid with highly similar properties, and is located in the I-band region of the N2-B isoform of the titin protein. This variant was not reported in population based cohorts in the following databases: Database of Single Nucleotide Polymorphisms (dbSNP), NHLBI Exome Sequencing Project (ESP), and 1000 Genomes Project. In the ESP, this variant was not observed in 6016 samples (12032 alleles) with coverage at this position. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |